{"unnormalised": "AIIMS Delhi announces breakthroughs in leukemia treatment protocols! Doctors are saying that the new line of treatment using drug XYZ-123 has shown promising results in initial trials.", "normalised": "A-I-I-M-S Delhi announces breakthroughs in leukemia treatment protocols! Doctors are saying that the new line of treatment using drug X-Y-Z-one hundred and twenty three has shown promising results in initial trials."}
{"unnormalised": "The trials, which began on 01/06/2024, involved patients with acute myeloid leukemia (AML). Approx. 70% of participants showed significant improvement in remission rates after just 3 cycles of the treatment. Dr. Rajesh Kumar, the lead oncologist, mentioned in a press briefing that \"These are preliminary findings, but the potential of XYZ-123 is truly exciting\". The cost per cycle is roughly Rs. 2,50,000, but AIIMS is working to make it more accessible.", "normalised": "The trials, which began on first June two thousand and twenty four, involved patients with acute myeloid leukemia (A-M-L). Approximately seventy percent of participants showed significant improvement in remission rates after just three cycles of the treatment. Doctor Rajesh Kumar, the lead oncologist, mentioned in a press briefing that \"These are preliminary findings, but the potential of X-Y-Z-one hundred and twenty three is truly exciting\". The cost per cycle is roughly rupee two hundred and fifty thousand, but A-I-I-M-S is working to make it more accessible."}
{"unnormalised": "However, some patients experienced side effects like nausea & fatigue, which are being carefully monitored. Further research is planned to optimize the dosage and manage adverse reactions. The study, funded by the ICMR (Indian Council of Medical Research), has been published in the 'Indian Journal of Medical Oncology'.", "normalised": "However, some patients experienced side effects like nausea and fatigue, which are being carefully monitored. Further research is planned to optimize the dosage and manage adverse reactions. The study, funded by the I-C-M-R (Indian Council of Medical Research), has been published in the 'Indian Journal of Medical Oncology'."}
{"unnormalised": "More updates are expected by the end of '24. If all goes well, this could seriously change the outlook for leukemia patients in India.", "normalised": "More updates are expected by the end of two thousand and twenty four. If all goes well, this could seriously change the outlook for leukemia patients in India."}
